...
首页> 外文期刊>Marine Drugs >Synthesis and Antitumor Activities of Derivatives of the Marine Mangrove Fungal Metabolite Deoxybostrycin
【24h】

Synthesis and Antitumor Activities of Derivatives of the Marine Mangrove Fungal Metabolite Deoxybostrycin

机译:海洋红树林真菌代谢产物脱氧宝霉素的合成及抗肿瘤活性

获取原文
           

摘要

Deoxybostrycin (1) is an anthraquinone compound derived from the marine mangrove fungus Nigrospora sp. No. 1403 and has potential to be a lead for new drugs because of its various biological properties. A series of new derivatives (2–22) of deoxybostrycin were synthesized. The in vitro cytotoxicity of all the new compounds was tested against MDA-MB-435, HepG2 and HCT-116 cancer cell lines. Most of the compounds exhibit strong cytotoxicity with IC50 values ranging from 0.62 to 10 μM. Compounds 19, 21 display comparable cytotoxicity against MDA-MB-435 to epirubicin, the positive control. The primary screening results indicate that the deoxybostrycin derivatives might be a valuable source of new potent anticancer drug candidates.
机译:Deoxybostrycin(1)是一种蒽醌化合物,衍生自海洋红树林真菌Nigrospora sp。 1403号,由于其各种生物学特性,有潜力成为新药的领先者。合成了一系列新的脱氧Bostrycin衍生物(2–22)。测试了所有新化合物对MDA-MB-435,HepG2和HCT-116癌细胞的体外细胞毒性。大多数化合物具有很强的细胞毒性,IC 50 值范围为0.62至10μM。化合物19、21对MDA-MB-435的阳性对照表现出与表柔比星相当的细胞毒性。初步筛选结果表明,脱氧葡萄孢菌素衍生物可能是新的有效抗癌药物候选物的宝贵来源。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号